The St Vincent's Potentially Inappropriate Medicines Study: Development of a Disease-Specific Consensus List and its Evaluation in Ambulatory Heart Failure Care
Open Access
- 1 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 16 (8) , 915-922
Abstract
Aims: Heart failure (HF) patients may be at risk of prescription of potentially inappropriate medicines (PIMs) yet no disease-specific list is available to assess PIM use in this population. A Consensus Potentially Inappropriate Medicines in Heart Failure (PIMHF) list was developed, assessed, and compared with an established, general tool in an ambulatory HF population. Methods and results: The Consensus PIMHF list was compiled using modified Delphi methodology with a multidisciplinary team. The list consisted of 11 items. The medication profile of 350 patients was assessed. The association of a Consensus PIMHF item use over a median follow-up period of 1.8 (interquartile range 1.3–2.1) years with the primary endpoint of death, acute hospitalization, or unscheduled outpatient visit was examined. Fifty-one patients (14.6%) were prescribed ≥1 Consensus PIMHF item. In univariable analysis, patients prescribed ≥1 Consensus PIMHF item were 58% more likely to experience the primary endpoint than those with none [95% confidence interval (CI) 1.02–2.45]. When adjusted for age, sex, and HF severity, this difference remained [hazard ratio (HR) 1.88, 95% CI 1.16–3.06] and these associations were in contrast to the use of a more general tool (HR 1.24, 95% CI 0.83–1.84). However, when further adjusted to include co-morbidity score and polypharmacy, there was no association with outcome using either tool (HR 1.40, 95% CI 0.83–2.38; HR 1.05, 95% CI 0.69–1.60, respectively). Conclusion: The Consensus PIMHF list provides the first HF-specific medicines review tool. These results provide some support for more disease-specific tools with limited lists of PIMs to rationalize medicines management in HF. However, more prospective work on the application of these tools in practice is needed.Keywords
Funding Information
- Health Services Executive
- Heartbeat Trust Registered Charity No. CHY 15398
This publication has 27 references indexed in Scilit:
- Effects of Pharmacists' Interventions on Appropriateness of Prescribing and Evaluation of the Instruments' (MAI, STOPP and STARTs') Ability to Predict Hospitalization–Analyses from a Randomized Controlled TrialPLOS ONE, 2013
- ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012European Journal of Heart Failure, 2012
- Co-Morbidity and Potential Treatment Conflicts in Elderly Heart Failure PatientsDrugs & Aging, 2011
- Trends in Comorbidity, Disability, and Polypharmacy in Heart FailureThe American Journal of Medicine, 2011
- Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressantsAge and Ageing, 2010
- Potentially inappropriate prescribing in an Irish elderly population in primary careBritish Journal of Clinical Pharmacology, 2009
- Potentially inappropriate medications in the elderly: a French consensus panel listEuropean Journal of Clinical Pharmacology, 2007
- Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trialBMJ, 2007
- Potentially Inappropriate Medication Use Among Elderly Home Care Patients in EuropeJAMA, 2005
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976